Mackay Shields LLC Kodiak Sciences Inc. Transaction History

Mackay Shields LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$77.2 - $126.54 $949,560 - $1.56 Million	-12,300 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$110.45 - $164.47 $894,645 - $1.33 Million	-8,100 Reduced 39.71%	12,300 $1.39 Million
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $206,652 - $523,702	-3,400 Reduced 14.29%	20,400 $3 Million
Q3 2020 Nov 04, 2020	SELL	$45.05 - $59.27 $13,515 - $17,781	-300 Reduced 1.24%	23,800 $1.41 Million
Q2 2020 Jul 31, 2020	BUY	$42.74 - $66.25 $269,262 - $417,375	6,300 Added 35.39%	24,100 $1.31 Million
Q1 2020 May 08, 2020	BUY	$38.18 - $73.95 $500,158 - $968,745	13,100 Added 278.72%	17,800 $849,000
Q4 2019 Feb 11, 2020	BUY	$13.9 - $76.65 $65,330 - $360,255	4,700 New	4,700 $338,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $462M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.